NanoInnovation in UNMET clinical needs - Part I


20 Sept.			09:00 - 10:30



HEALTH & NANOMEDICINE
NANOMEDICINE
TT.I - Technical Multi-Track with Parallel SYMPOSIA
NanoInnovation in UNMET clinical needs - Part I
Co-organized with Don Gnocchi Foundation, University of Modena and Reggio Emilia Chair: Alexandre CECCALDI - CV, General Secretary of the European Technology Platform on Nanomedicine (ETPN)
The session will deal with precise approaches for diagnosis and therapy, as well as gene therapy and drug-based RNA/DNA technologies with applications in cancer, neurological diseases, cardiovascular, rare and genetic diseases. The session will deal with the most applied technologies in the field of nanotechnology applied to medicine, open up to innovations in different fields of applications. Besides, a plethora of speakers from Controlled Release Society, Adritelf, and European Technology Platform for Nanomecidicine will present.

TT.I.D.1	Lorena DIÉGUEZ - CV INL & CEO at RUBYnanomed Using nanodiagnostics to evaluate circulating biomarkers
TT.I.D.2	Laurent LÉVY CEO at Nanobiotix European Technology Platform for Nanomedicine - Talk 2
TT.I.D.3	Mareike WERLE - CV William Harvey Research Institute/Queen Mary University London Polymer nanoparticles as a targeted drug delivery system for the treatment of rheumatoid arthritis
TT.I.D.4	Ilaria OTTONELLI - CV University of Modena and Reggio Emilia Nanomedicine evolution and perspective
TT.I.D.5	Francesca RE - CV University of Milano Bicocca Glioblastoma Tunneling Nanotubes as potential targets for nanomedicine: an in vitro investigation on advanced cellular model